GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $341,000 | -5.8% | 8,400 | 0.0% | 0.16% | -6.9% |
| Q2 2017 | $362,000 | +2.3% | 8,400 | 0.0% | 0.17% | -8.0% |
| Q1 2017 | $354,000 | +9.6% | 8,400 | 0.0% | 0.19% | +5.6% |
| Q4 2016 | $323,000 | +1.3% | 8,400 | +13.5% | 0.18% | -1.7% |
| Q3 2016 | $319,000 | -0.6% | 7,400 | 0.0% | 0.18% | -3.2% |
| Q2 2016 | $321,000 | +27.9% | 7,400 | +19.4% | 0.19% | +23.8% |
| Q1 2016 | $251,000 | – | 6,200 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |